Every open market buy and sale of Dyne Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $315K bought and $169M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when DYN insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an DYN officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every DYN insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | John CoxCEO & President | Sale plan | 5,513 | $16.82 | $93K | 351,994 | Nov 16Form 4 |
| Nov 13, 2026 | Erick LuceraCFO | Sale plan | 1,991 | $16.82 | $33K | 117,775 | Nov 16Form 4 |
| Nov 13, 2026 | Douglas KerrHead of R&D and CMO | Sale plan | 2,604 | $16.82 | $44K | 167,960 | Nov 16Form 4 |
| Nov 13, 2026 | Johanna Friedl-NadererChief Commercial Officer | Sale plan | 231 | $16.82 | $4K | 152,666 | Nov 16Form 4 |
| Oct 2, 2026 | Brian S PosnerDirector | Buy | 2,500 | $16.00 | $40K | 27,000 | Oct 6Form 4 |
| Sep 8, 2026 | John CoxCEO & President | Sale plan | 5,658 | $18.88 | $107K | 357,507 | Sep 8Form 4 |
| Sep 8, 2026 | Douglas KerrChief Medical Officer | Sale plan | 5,035 | $22.95 | $116K | 162,564 | Sep 8Form 4 |
| Sep 8, 2026 | Johanna Friedl-NadererChief Commercial Officer | Sale plan | 1,085 | $23.42 | $25K | 152,897 | Sep 8Form 4 |
| Aug 14, 2026 | Jason P RhodesDirector | Sale plan | 2,586,928 | $25.20 | $65.2M | 428,946 | Aug 17Form 4 |
| Aug 13, 2026 | John CoxCEO & President | Sale plan | 4,986 | $26.28 | $131K | 363,165 | Aug 17Form 4 |
| Aug 13, 2026 | Erick LuceraCFO | Sale plan | 1,797 | $26.28 | $47K | 119,766 | Aug 17Form 4 |
| Aug 13, 2026 | Douglas KerrChief Medical Officer | Sale plan | 1,556 | $26.28 | $41K | 167,599 | Aug 17Form 4 |
| Aug 13, 2026 | Johanna Friedl-NadererChief Commercial Officer | Sale plan | 226 | $26.28 | $6K | 153,982 | Aug 17Form 4 |
| Jul 27, 2026 | Dirk KerstenDirector | Sale plan | 261,460 | $25.51 | $6.7M | 3,586,796 | Jul 29Form 4 |
| Jul 7, 2026 | Jason P RhodesDirector | Sale plan | 777,451 | $22.97 | $17.9M | 2,962 | Jul 8Form 4 |
DYN insider trading FAQ
Are DYN insiders buying or selling?
Insiders are net sellers over the last 12 months. 1 insiders bought $315K of DYN on the open market in 8 trades, and 6 sold $169M in 42 trades, 100% of that under pre-arranged trading plans.
When did an DYN insider last buy shares?
Brian S Posner (Director) bought 2,500 shares for $40K on Oct 2, 2026, reported on Oct 6, 2026.
When did an DYN insider last sell shares?
John Cox (CEO & President) sold 5,513 shares for $93K on Nov 13, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
